Search Results

Olink Holding AB announced that the Baylor College of Medicine Human Genome Sequencing Center has selected the Olink Explore platform as a proteomics component of their world-class multiomics offering.

Baylor Genetics today announced the availability of a new RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS).

Genome Insight, a clinical laboratory, is proud to announce its accreditation by the College of American Pathologists (CAP) for its whole genome sequencing services.

Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced their companies’ selection by the University of California, Irvine and the GREGoR Consortium to support the Pediatric Mendelian Genomics Research Center program to better understand the underlying biology of rare diseases.

MaxCyte, Inc. and Be Biopharma announced the signing of a strategic platform license to support the development of Be Bio’s BCMs programs.

Complete Genomics, a pioneering genomic sequencing company, announced the May 22 opening of its Customer Experience Center demonstration lab near Boston’s biotech hub.

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, will showcase its latest advancements and research discoveries at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting on March 12-16 in Toronto, Canada.